Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →A patent landscape review of emulsion liquid membrane and liquid surfactant membrane extraction technology: filing trends, leading assignees, IPC composition and where claim space remains open, covering 2015 through the
Filing growth = 2021 (4 records) → 2024 (2); 2024 is the last year we treat as complete. Top-5 share = the 5 largest assignees ÷ all 93 records in scope (CR5), not the ranked leaders only.
Emulsion liquid membrane (ELM) and liquid surfactant membrane extraction use a thin surfactant-stabilised oil film to selectively transport a target species between an aqueous feed and a stripping phase. The technique appears across three quite different industrial contexts in this dataset: separation and filtration engineering under B01D, water and wastewater treatment under C02F, and metal recovery under C22B, with smaller pockets in hydrocarbon processing, peptide separation and biomedical devices. Because a single filing can straddle several of these uses, the same underlying membrane chemistry is claimed from very different angles depending on the assignee's end market.
The scope here is 93 published records dated 2015-01-01 through the 2026-08-31 cut-off, drawn from a search string anchored on emulsion liquid membrane and liquid surfactant membrane terms combined with extraction, separation, selective transport and stripping. Patent families, not raw document counts, are the ranking unit, which keeps continuation filings and multi-jurisdiction duplicates from inflating any single assignee's position.
Two views of the same 93-record set: how filing activity has moved year over year, and which IPC subclasses carry the claim density.
Annual filings ran from 4 in 2017 to a peak of 5 in 2025, with 2021 at 4 and 2024 at 2 — a -50% move over that three-year span. 2026 shows only 1 record so far, and 2025-2026 both understate true filing activity because publication trails filing by roughly 18 months; treat the recent downturn as provisional rather than a confirmed slowdown.
Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.
B01D (separation processes) appears in 58.1% of the 93 records and C02F (water and wastewater treatment) in 44.1%, making general separation engineering and water treatment the two dominant use cases. C22B (metal extraction and refining) reaches 12.9%, well behind the top two despite metal recovery being the subject of the most recently featured filing, and smaller subclasses — C07C, A61M, C10G, C07K, C09K — each sit under 8%, indicating narrower, less contested niches.
Shares are the percentage of the 93 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about emulsion liquid membrane extraction patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaFiled by BGRIMM Technology Group and published 2025-04-17, this filing sets out a full process for extracting gallium from leaching solution: preparing the emulsion liquid membrane system, running extraction and de-extraction, and optimising factors such as the gallium solution-to-emulsion volume ratio, extractant concentration, sulfuric acid concentration and emulsion stirring duration through fractional factorial and central composite experimental design.It sits in the C22B metal-extraction subclass, the smaller of the two dominant technology branches in this dataset, and illustrates how ELM process claims are now being tuned for specific critical-metal recovery targets rather than left as generic extraction methods.

| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20120080377A1 | Biomimetic membranes and uses thereof | 72 |
| 2 | WO2010146365A1 | Biometric membranes and uses thereof | 59 |
| 3 | US5868935A | Method and apparatus for extraction and recovery of ions from solutions | 41 |
| 4 | US3719590A | Liquid membrane system for separation of components of liquid mixtures | 30 |
| 5 | CN2508830Y | 乳状液旋流脉冲高压静电连续破乳器 | 19 |
| 6 | WO2000029337A1 | A system and a method for removing ions from aqueous liquid streams | 19 |
| 7 | CN102802770A | 仿生膜及其用途 | 18 |
| 8 | US3389078A | Liquid separation through a permeable membrane in droplet form | 18 |
| 9 | CN101418375A | 液膜提金-隔膜电解提金工艺 | 15 |
| 10 | US5229004A | Stabilizing of liquid membranes for separation processes without sacrificing permeability by non-Newtonian co… | 15 |
Citation counts favour older records simply by having had more time to accumulate them; read them as a signal of foundational influence, not of which claims matter most today.
Patent titles are shown in the language they were filed in, not translated, so that each record stays verifiable against the original filing — a translated title will not match in Eureka or in any national register. Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Four read-throughs of the assignee, trend and classification data that matter for deciding where to file next.
One assignee holds 24 records outright, and the top five combined account for 43.0% of all 93 records in scope; the top ten reach 53.8%. That leaves a long tail of single- and few-filing entrants below rank ten — the pattern of a field with an established leader rather than open competition.
B01D separation-process claims and C02F water-treatment claims cover the large majority of records, while C22B metal extraction — the subclass of the most recent featured filing — reaches only 12.9%. A membrane chemistry claim written broadly for separation may still read onto a narrower metal-recovery implementation, and vice versa.
The complete-year trend shows a decline from 4 filings in 2021 to 2 in 2024. 2025 and 2026 figures should not be read as a continuation of that decline, since publication lags filing by roughly 18 months and both years are still filling in.
China accounts for the largest share of receiving-office filings at 34, ahead of the United States at 13 and India at 11; Malaysia, WIPO/PCT and Australia trail behind. That distribution points to where enforcement and freedom-to-operate checks matter most for anyone commercialising ELM processes.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to emulsion liquid membrane extraction patent landscape, with the prior art for and against each one.
The numbers above answer what the field looks like; the questions below are where a technical or legal team usually goes next.
With one assignee holding 24 of 93 records, a new filing in the same subclass needs a clause-by-clause read of that portfolio before drafting.
Explore claim mapping in EurekaC22B sits at only 12.9% of records yet holds the most recently featured filing — a sign this branch may still have open claim space worth testing.
Run a white-space search in EurekaBecause publication lags filing by roughly 18 months, the true trajectory of recent activity will only become visible over the next reporting cycles.
Set up monitoring in EurekaThe assignee ranking covers 54 companies drawn from 93 records in scope, and it is a genuinely top-heavy field: one leader holds 24 records, and the top five combined hold 43.0% of all filings. Below the top ten, which together hold 53.8%, the ranking thins into a long tail of assignees with only one or two filings each. Anyone assessing competitive position should treat the top ten as the group actually setting claim boundaries, and everyone below as opportunistic or narrowly focused filers.
Most records sit in B01D (separation processes), which touches 58.1% of the 93 records, and C02F (water and wastewater treatment), at 44.1%. Metal extraction and refining under C22B reaches 12.9%, and smaller pockets exist in hydrocarbon oil processing, peptide separation, biomedical fluid devices and specialty materials, each under 8%. Because a single filing can be classified under several of these subclasses, the shares add up to more than 100% and should be read as overlapping coverage rather than a strict breakdown.
Complete-year data shows filings falling from 4 in 2021 to 2 in 2024, a -50% change over that span. It would be a mistake to extend that decline into 2025 and 2026: publication typically lags actual filing by roughly 18 months, so the most recent one to two years in any patent dataset are undercounted until later filings catch up in the record. The peak year in the raw data so far is actually 2025, at 5 filings, which itself will likely revise upward.
The metal-extraction branch under C22B stands out: it covers only 12.9% of the 93 records despite hosting the dataset's most recently featured filing, a gallium-recovery process. Smaller subclasses such as C07K (peptides and proteins) and C09K (materials for miscellaneous applications) sit at 3.2% each, suggesting narrow, lightly contested niches rather than a crowded field. A first mover pairing a specific target compound or metal with a defined membrane composition in one of these lower-density subclasses has more room to stake a broad claim than someone filing again in B01D or C02F.
China is the largest receiving office in this dataset with 34 records, followed by the United States at 13 and India at 11; Malaysia, the WIPO/PCT route and Australia account for smaller counts. That concentration in China reflects both the domestic filing volume and the presence of several Chinese assignees named in the underlying data. Companies planning to commercialise ELM-based extraction should prioritise freedom-to-operate review in China and the United States first, given where the bulk of enforceable rights are currently filed.
Go past this page: query the whole emulsion liquid membrane extraction patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.
Help us improve
Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.
This page